Information about at.las
My details
*
*
*

at.las (ASBL)

Company information

Status
Active

Enterprise number

BE0732.572.407

VAT liability
No
Established
13-08-2019
Last balance sheet year
N/A
Company size
N/A 0 FTE
Full name
Leveraging Affordable Solutions for Advanced Therapies
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Publications from at.las

Date Publication
16-08-2019 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the enterprise number of Leveraging Affordable Solutions for Advanced Therapies?
The enterprise number of Leveraging Affordable Solutions for Advanced Therapies is BE 0732.572.407.
Wat is the PEPPOL ID of Leveraging Affordable Solutions for Advanced Therapies?
There is no information available about the PEPPOL ID of Leveraging Affordable Solutions for Advanced Therapies or the company is not yet registered on the PEPPOL network.
When was Leveraging Affordable Solutions for Advanced Therapies founded?
Leveraging Affordable Solutions for Advanced Therapies was founded on 13-08-2019.
What is the address of Leveraging Affordable Solutions for Advanced Therapies?
The current registered office of Leveraging Affordable Solutions for Advanced Therapies is located at Galileilaan 15, 2845 Niel.
When was the last time Leveraging Affordable Solutions for Advanced Therapies filed their annual financial statements?
Leveraging Affordable Solutions for Advanced Therapies has not (yet) filed any financial statements.
How many employees does Leveraging Affordable Solutions for Advanced Therapies have?
Leveraging Affordable Solutions for Advanced Therapies has not (yet) filed any financial statements or no staff information is available.
What is the annual turnover of Leveraging Affordable Solutions for Advanced Therapies?
There is no turnover available for Leveraging Affordable Solutions for Advanced Therapies.